G Landa, W Amde, V Doshi, A Ali, L McGevna … - Ophthalmologica, 2009 - content.karger.com Aims: To compare the safety and efficacy of 2 anti-vascular-endothelial-growth-
factor agents - bevacizumab (Avastin) versus ranibizumab (Lucentis) - in the
treatment of patients with neovascular age-related macular degeneration ... Cited by 1 - Related articles - All 4 versions
H Wu, TC Chen - Seminars in Ophthalmology, 2009 - informahealthcare.com Intraocular pressure (IOP) changes, especially IOP elevation, are one of several
possible complications of IVIs. Even transient IOP elevations can be associated
with visual field defects. 22 , 23 This is a particularly devastating ... Related articles - All 5 versions